Zobrazeno 1 - 10
of 581
pro vyhledávání: '"59"'
Autor:
Roberto Tapia-Conyer, Rodrigo Saucedo-Martínez, Jorge Abelardo Falcón-Lezama, Myrna María Alfaro-Cortes, Miguel Betancourt-Cravioto
Publikováno v:
Vaccines
Volume 9
Issue 3
Vaccines, Vol 9, Iss 188, p 188 (2021)
Volume 9
Issue 3
Vaccines, Vol 9, Iss 188, p 188 (2021)
The Mexican influenza vaccination program does not include a recommendation for people aged 50–59 years without risk factors for influenza complications, and there are limited data regarding the cost-effectiveness of vaccinating this population. To
Autor:
Karine Dubé, Liza Dawson, David M. Margolis, Jeremy Sugarman, Adam Gilbertson, Stuart Rennie, S. Garner, Randall Tressler, Jintanat Ananworanich
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss, Pp 30-(2016)
Publikováno v:
The Pediatric infectious disease journal. 11(5)
Since 1987 Haemophilus influenzae b (Hib) conjugate vaccines have been licensed for use in children ages 18 months and older. Before licensure there were no clinical trials of a single dose of any conjugate vaccine in children ages 18 months or older
Publikováno v:
International Journal of Infectious Diseases. 10:S33
Autor:
L. N. Golitsyna, V. V. Zverev, N. I. Romanenkova, M. T. Luong, S. G. Selivanova, A. V. Leonov, N. A. Novikova, N. R. Rozaeva, T. T. T. Nguyen, Ponomareva Nv, M. A. Bichurina, O. I. Kanaeva
Publikováno v:
Infekciâ i Immunitet, Vol 11, Iss 5, Pp 905-916 (2021)
The epidemic situation and etiological factors of enterovirus infection in Russia and Vietnam were analysed and compared. The identified strains of enteroviruses of 47 types, which circulated in Russia in 2018–2019, belonged to different species: E
Publikováno v:
The Journal of Infectious Diseases. 223:1992-2000
Background Human papillomaviruses (HPV) cause several human cancers. Bivalent (Cervarix) and quadrivalent (qGardasil) HPV vaccines both contain virus-like particles of the major oncogenic HPV types 16 and 18, but also cross-protect against some nonva
Publikováno v:
Pathogens and Immunity, Vol 5, Iss 1, Pp 275-290 (2020)
Pathogens and Immunity
Pathogens and Immunity
Background: Direct-acting antiviral (DAA) therapy among hepatitis C virus (HCV)-infected kidney transplant recipients is associated with short-term improvement in protein/creatinine (P/C) ratios, but how HCV cure affects long-term graft outcomes rema
Autor:
Carlos Roberto de Medeiros, Patrícia Emília Braga, Esper G. Kallas, Vivian Iida Avelino-Silva, Ana Marli Christovam Sartori, Marisol Simões, Karina Takesaki Miyaji, Marcos da Silva Freire, Maria Angélica Acalá Neves, Marta Heloísa Lopes
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Volume: 59, Article number: e2, Published: 03 APR 2017
Revista do Instituto de Medicina Tropical de São Paulo, Vol 59, Iss 0
Revista do Instituto de Medicina Tropical de São Paulo
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2
Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e2
Instituto de Medicina Tropical (IMT)
instacron:IMT
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Revista do Instituto de Medicina Tropical de São Paulo, Vol 59, Iss 0
Revista do Instituto de Medicina Tropical de São Paulo
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 59 (2017); e2
Revista do Instituto de Medicina Tropical de São Paulo; v. 59 (2017); e2
Instituto de Medicina Tropical (IMT)
instacron:IMT
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in pre
Autor:
Ana M. Espino, Tiffany Rosa-Arocho, Amelia K. Pinto, Crisanta Serrano-Collazo, Albersy Armina-Rodriguez, Petraleigh Pantoja, Lorna Cruz, Christina Pabon-Carrero, Dianne Atehortua, James D. Brien, Gerardo Latoni, Teresa Arana, E. Taylor Stone, Carlos A. Sariol, Consuelo Climent
Publikováno v:
Viruses
Volume 13
Issue 10
Viruses, Vol 13, Iss 1972, p 1972 (2021)
Volume 13
Issue 10
Viruses, Vol 13, Iss 1972, p 1972 (2021)
Both the SARS-CoV-2 pandemic and emergence of variants of concern have highlighted the need for functional antibody assays to monitor the humoral response over time. Antibodies directed against the spike (S) protein of SARS-CoV-2 are an important com
Autor:
Neil Formica, Raburn Mallory, Gary Albert, Michelle Robinson, Joyce S Plested, Iksung Cho, Andreana Robertson, Filip Dubovsky, Gregory M Glenn, 2019nCoV-101 Study Group
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 18, Iss 10, p e1003769 (2021)
PLoS Medicine, Vol 18, Iss 10, p e1003769 (2021)
Background NVX-CoV2373 is a recombinant severe acute respiratory coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant. Methods and findings The phase 2 component of ou